Altered plasma albumin characteristics and lymphocyte populations in gastrointestinal cancer patients: Detection using modified fluorescence responses

References

• Alessio, M., Roggero, S., Funaro, A., De Monte, L. B., Peruzzi, L., Geuna, M., Malavasi, F. 1990. CD38 molecule: Structural and biochemical analysis on human T-lymphocytes, thymocytes, and plasma cells. J. Immunol. 145:878–884.
   PubMed Web of Science ®Google Scholar
• Cesano, A., Visonneau, S., Deaglio, S., Malavasi, F., and Santoli, D. 1998. Role of CD38 and its ligand in the regulation of MHC-non-restricted cytotoxic T-cells. J. Immunol. 160:1106–1115.
   PubMed Web of Science ®Google Scholar
• Deaglio, S., Dianzani, U., Horenstein, A. L., Fernandez, J. E., van Kooten C., Bragardo, M., Funaro, A., Garbarino, G., Di Virgilio, F., Banchereau, J., and Malavasi, F. 1996. Human CD38 ligand: A 120-kDa protein predominantly expressed on endothelial cells. J. Immunol. 156:727–734.
   PubMed Web of Science ®Google Scholar
• Deterre, P., Berthelier, V., Bauvois, B., Dalloul, A., Schuber, F., and Lund, F. 2000. CD38 in T- and B-cell functions. Chem. Immunol. 75:146–168.
   PubMedGoogle Scholar
• Dianzani, U., and Malavasi, F. 1995. Lymphocyte adhesion to endothelium. Crit. Rev. Immunol. 15:167–200.
   PubMed Web of Science ®Google Scholar
• Dianzani, U., Funaro, A., DiFranco, D., Garbarino, G., Bragardo, M., Redoglia, V., Buonfiglio, D., De Monte, L. B., Pileri, A., and Malavasi, F. 1994. Interaction between endothelium and CD4+CD45RA+ lymphocytes. Role of the human CD38 molecule. J. Immunol. 153:952–959.
   PubMed Web of Science ®Google Scholar
• Duncan, D. B. 1970. Query multiple comparison methods for comparison methods for comparing regression coefficient. Biometrics 26:141–143.
   Web of Science ®Google Scholar
• Funaro, A., Spagnoli, G. C., Ausiello, C. M., Alessio, M., Roggero, S., Delia, D., Zaccolo, M., and Malavasi, F. 1990. Involvement of the multilineage CD38 molecule in a unique pathway of cell activation and proliferation. J Immunol. 145:2390–2396.
   PubMed Web of Science ®Google Scholar
• Grizunov, Y. A., and Dobretsov, G. E. (Eds.). 1994. Plasma Albumin in Clinical Medicine. Moscow: Irius Publishers.
   Google Scholar
• Kalnina, I., and Meirovics, I. 1999. A new fluorescent probe, ABM: Properties and application in clinical diagnostics. J. Fluorescence 9:27–32.
   Web of Science ®Google Scholar
• Kalnina, I., Meirovics, I., and Rashkina, E. 1996. Some benzanthrone amino derivatives as potential fluorescent probes. Funct. Mater. 3:551–555.
   Google Scholar
• Kalnina, I., Bruvere, R., Gabruseva, N., Zvagule, T., Heisele, O., Volrate, A., Feldmane, G., and Meirovics, I. 2004. Phenotypical characteristics of leukocytes of Chernobyl clean-up workers from Latvia: Use of fluorescent probe ABM. Biol. Memb. 21:72–78.
   Web of Science ®Google Scholar
• Kalnina, I., Zvagule, T., Bruvere, R., and Meirovics, I. 2005. Fluorescent characteristics of rheumatoid arthritis patients blood lymphocytes. J. Fluorescence 15:105–110.
   PubMed Web of Science ®Google Scholar
• Kalnina, I., Bruvere, R., Zvagule, T., Gabruseva, N., Volrate, A., Feldmane, G., Klimkane, L., Kirilova, J., and Meirovics, I. 2006. Immune state of patients with different pathologies monitored by fluorescent probe 3-aminobenzanthrone derivative. Proc. Latvian Acad. Sci., Sec. B 60:113–120.
   Google Scholar
• Kalnina, I., Klimkane, L., Kirilova, E., Toma, M. M., Kizane, G., and Meirovics, I. 2007a. Fluorescent probe ABM for screening gastrointestinal patient’s immune state. J. Fluorescence 17:619–625.
   PubMed Web of Science ®Google Scholar
• Kalnina, I., Zvagule, T., Gabruseva, N., Kirilova, J., Kurjane, N., Bruvere, R., Kesters, A., Kizane, G., Kirilovs, G., and Meirovics, I. 2007b. Structural changes in lymphocyte membrane of Chernobyl clean-up workers from Latvia. J. Fluorescence 17:633–638.
   PubMed Web of Science ®Google Scholar
• Lakowicz, J. R. (Ed.) 1999. Principles of Fluorescence Spectroscopy, 2nd ed. New York: Kluwer Academic/Plenum Press.
   Google Scholar
• Lakowicz, J. R. (Ed.) 2000. Protein Fluorescence. Vol. 6. New York: Plenum Press.
   Google Scholar
• Lund, F. E., Muller-Steffner, H. M., Yu, N., Stout, C. D., Schuber, F., Howard, M. C. 1999. CD38 signaling in B-lymphocytes is controlled by its ectodomain but occurs independently of enzymatically-generated ADP-ribose or cyclic ADP-ribose. J. Immunol. 162:2693–2702.
   PubMed Web of Science ®Google Scholar
• Palmer, S., Hanson, C. A., Zent, C. S., Porrata, L. F., Laplant, B., Geyer, S. M., Markovic, S. N., Call, T. G., Bowen, D. A., Jelinek, D. F., Kay, N. E., and Shanafelt, T. D. 2008. Prognostic importance of T- and NK-cells in a consecutive series of newly-diagnosed patients with chronic lymphocytic leukaemia. Br. J. Haematol. 141:607–614.
   PubMed Web of Science ®Google Scholar
• Petitpas, I., Bhattacharya, A. A., Twine, S., East, M., and Curry, S. 2001a. Crystal structure analysis of warfarin binding to human serum albumin: Anatomy of drug site I. J. Biol. Chem. 276:22804–22809.
   PubMed Web of Science ®Google Scholar
• Petitpas, I., Grune T., Bhattacharya, A., and Curry, S. 2001b. Crystal structures of human serum albumin complexed with monounsaturated and polyunsaturated fatty acids. J. Mol. Biol. 314:955–960.
   PubMed Web of Science ®Google Scholar
• Petitpas, I., Petersen, C. E., Ha, C. E., Bhattacharya, A. A., Zunszain, P. A., Ghuman, J., Bhagavan, N. V., and Curry, S. 2003. Structural basis of albumin-thyroxine interactions and familial dysalbuminemic hyperthyroxinemia. Proc. Natl. Acad. Sci. USA 100:6440–6445.
   PubMed Web of Science ®Google Scholar
• Rolinski, O. J., Martin, A., and Birgh, D. J. 2007. Human serum albumin and quercetin interactions monitored by time resolved fluorescence evidence of enhanced discrete rotamer conformations. J. Biomed. Optics 12:34013-1–34013-7.
   PubMed Web of Science ®Google Scholar
• Sandoval-Montes, C., and Santos-Argumedo, L. 2005. CD38 is expressed selectively during the activation of a subset of mature T-cells with reduced proliferation but improved potential to produce cytokines. J. Leukocyte Biol. 77:513–521.
   PubMed Web of Science ®Google Scholar
• Schulster D., and Levitzki A. (Eds.) 1980. Cellular Receptors for Hormones and Neurotransmitters. New York: John Wiley & Sons.
   Google Scholar
• Sharma, R., Zucknick, M., London, R., Kacevska, M., Liddle, C., and Clarke, S. J. 2008. Systemic inflammatory response predicts prognosis in patients with advanced-stage colorectal cancer. Clin. Colorectal Cancer 7:331–337.
   PubMed Web of Science ®Google Scholar
• Shubinsky, G., and Schlesinger, M. 1996. The mechanism of IL-4-induced down-regulation of CD38 on human B-cells. Cell. Immunol. 173:87–95.
   PubMed Web of Science ®Google Scholar
• Slavik, J. 1982. Anilinonaphtalene sulfonate as a probe of membrane composition and function. Biochim. Biophys. Acta 694:1–25.
   PubMed Web of Science ®Google Scholar
• Togashi D., and Ryder A. G. 2006. A fluorescent analysis of ANS bound to bovine serum albumin. Binding properties revisited. Proceedings of the 10th Conference on Methods and Applications of Fluorescence, 9–12 September, Salzburg, Austria, p. 254.
   Google Scholar
• Togashi, D. M., and Ryder, A. G. 2007. Time-resolved fluorescence studies on bovine albumin denaturation process. J. Fluorescence 16:153–160.
   Web of Science ®Google Scholar
• Wykes, M. N., Lynette Beattie L., Gordon, G., MacPherson, G. G., and Hart, D. N. 2004. Dendritic cells and follicular dendritic cells express a novel ligand for CD38 which influences their maturation and antibody responses. Immunology 113:318–327.
   PubMed Web of Science ®Google Scholar